Circ_RPPH1 facilitates progression of breast cancer via miR-1296-5p/TRIM14 axis

References

• Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E, Farahmand L. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. doi:10.1016/j.intimp.2020.106535.
   PubMed Web of Science ®Google Scholar
• Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033. doi:10.1259/bjr.20211033.
   PubMed Web of Science ®Google Scholar
• Hamdan D, Nguyen TT, Leboeuf C, Meles S, Janin A, Bousquet G. Genomics applied to the treatment of breast cancer. Oncotarget. 2019;10(46):4786–14. doi:10.18632/oncotarget.27102.
   PubMedGoogle Scholar
• Nelson AJO, America GCON. Controversies regarding mammography, breast self-examination, and clinical breast examination. Obstet Gynecol Clin North Am. 2013;40(3):413–427. doi:10.1016/j.ogc.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. Global increase in breast cancer incidence: Risk factors and preventive measures. Biomed Res Int. 2022;2022:1–16. doi:10.1155/2022/9605439.
   Web of Science ®Google Scholar
• Fiorica J. Breast cancer screening, mammography, and other modalities. Clin Obstet Gynecol. 2016;59(4):688–709. doi: 10.1097/GRF.0000000000000246.
   PubMed Web of Science ®Google Scholar
• Cserni G, Chmielik E, Cserni B, Tot T. The new TNM-based staging of breast cancer. Virchows Arch. 2018;472(5):697–703. doi:10.1007/s00428-018-2301-9.
   PubMed Web of Science ®Google Scholar
• Fisusi F, Akala E. 2019. Drug combinations in breast cancer therapy. Pharm Nanotechnol. 7(1):3–23. doi: 10.2174/2211738507666190122111224.
   PubMedGoogle Scholar
• Haussmann J, Corradini S, Nestle-Kraemling C, Bölke E, Njanang FJD, Tamaskovics B, Orth K, Ruckhaeberle E, Fehm T, Mohrmann S, et al. 2020. Recent advances in radiotherapy of breast cancer. Radiat Oncol. 15(1):71. doi: 10.1186/s13014-020-01501-x.
   PubMed Web of Science ®Google Scholar
• Yin L, Duan J-J, Bian X-W, Yu S-C. 2020. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22(1):61. doi: 10.1186/s13058-020-01296-5.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng W, Ji C, Wang X, Yu Y, Deng X, Zhou X, Fang L. Circular RNA circRPPH1 promotes breast cancer progression via circRPPH1-miR-512-5p-STAT1 axis. Cell Death Discov. 2021;7(1):376. doi:10.1038/s41420-021-00771-y.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li L, Li Z, Xu J, Yang Q, Shi P, Zhang K, Jiang R. A novel circular RNA hsa_circRPPH1_015 exerts an oncogenic role in breast cancer by impairing miRNA-326-mediated ELK1 inhibition. Front Oncol. 2020;10:906. doi:10.3389/fonc.2020.00906.
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Cheng H. Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2. Clin Breast Cancer. 2022;22(3):e286–e295. doi:10.1016/j.clbc.2021.08.009.
   PubMed Web of Science ®Google Scholar
• Xie J, Ye F, Deng X, Tang Y, Liang J-Y, Huang X, Sun Y, Tang H, Lei J, Zheng S, et al. Circular RNA: A promising new star of vaccine. J Transl Int Med. 2023;11(4):372–381. doi:10.2478/jtim-2023-0122.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu Z, Ma J, Wang H, Gao D, Zhang C, Ma Q. CircRPPH1 serves as a sponge for miR-296-5p to enhance progression of breast cancer by regulating FOXP4 expression. Am J Transl Res. 2021;13(7):7556–7573.
   PubMed Web of Science ®Google Scholar
• Feng H, Sun S-Z, Cheng F, Zhang N-Q. Mediation of circ_RPPH1 on miR-146b-3p/E2F2 pathway to hinder the growth and metastasis of breast carcinoma cells. Aging (Albany NY). 2021;13(16):20552–20568. doi:10.18632/aging.203439.
   PubMedGoogle Scholar
• Yuan Y, Anbalagan D, Lee LH, Samy RP, Shanmugam MK, Kumar AP, Sethi G, Lobie PE, Lim LHK. ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation. Oncotarget. 2016;7(19):27007–27020. doi:10.18632/oncotarget.8875.
   PubMedGoogle Scholar
• Kristensen L, Jakobsen T, Hager H, Kjems J. The emerging roles of circRnas in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188–206. doi:10.1038/s41571-021-00585-y.
   PubMed Web of Science ®Google Scholar
• Wang P, Qu H, Wang L, Hu Z. Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p/MTA1 axis. Thorac Cancer. 2023;14(22):2198–2209. doi:10.1111/1759-7714.15007.
   PubMed Web of Science ®Google Scholar
• Chen G, He M, Yin Y, Yan T, Cheng W, Huang Z, Zhang L, Zhang H, Liu P, Zhu W, et al. miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer. Cancer Cell Int. 2017;17(1):95. doi:10.1186/s12935-017-0466-y.
   PubMedGoogle Scholar
• Xie F, Xiong Y, Yan J, Wang L, Yan W. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis. Bioengineered. 2022;13(2):1963–1974. doi:10.1080/21655979.2021.1995990.
   PubMed Web of Science ®Google Scholar
• Qi L, Sun B, Yang B, Lu S. CircRNA RPPH1 facilitates the aggravation of breast cancer development by regulating miR-542-3p/ARHGAP1 pathway. Cancer Biother Radiopharm. 2022;37(8):708–719. doi:10.1089/cbr.2020.4381.
   PubMed Web of Science ®Google Scholar
• Rahman S, Al–Marzouki A, Otim M, Khalil Khayat NEH, Yousuf R, Rahman P. Awareness about breast cancer and breast self-examination among female students at the University of Sharjah: A cross-sectional study. Asian Pac J Cancer Prev. 2019;20(6):1901–1908. doi:10.31557/APJCP.2019.20.6.1901.
   PubMedGoogle Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Chen W, Yu X, Wang N, Jing J, Li R, Lian M. Circ_RPPH1 regulates glioma cell malignancy by binding to miR-627-5p/miR-663a to induce SDC1 expression. Metab Brain Dis. 2022;37(4):1231–1245. doi:10.1007/s11011-022-00965-y.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhao L-M, Bai H-Y, Zhang C, Dai S-L, Lv H-L, Shan B-E. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Biosci Rep. 2019;39(1):BSR20181556. doi:10.1042/BSR20181556.
   PubMedGoogle Scholar
• Wang L, Hu K, Chao Y, Wang X. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2. J Cell Biochem. 2020;121(2):2038–2046. doi:10.1002/jcb.29438.
   PubMed Web of Science ®Google Scholar
• Xiao F, Ouyang B, Zou J, Yang Y, Yi L, Yan H. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway. Drug Dev Res. 2020;81(5):544–550. doi:10.1002/ddr.21650.
   PubMed Web of Science ®Google Scholar
• Su X, Wang J, Chen W, Li Z, Fu X, Yang A. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget. 2016;7(9):9939–9950. doi:10.18632/oncotarget.6941.
   PubMedGoogle Scholar
• Tan Z, Song L, Wu W, Zhou Y, Zhu J, Wu G, Cao L, Song J, Li J, Zhang W. TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2. Oncogene. 2018;37(40):5403–5415. doi:10.1038/s41388-018-0344-7.
   PubMed Web of Science ®Google Scholar
• Hu G, Pen W, Wang M. TRIM14 promotes breast cancer cell proliferation by inhibiting apoptosis. Oncol Res. 2019;27(4):439–447. doi:10.3727/096504018X15214994641786.
   PubMed Web of Science ®Google Scholar
• Yao X, Tu Y, Xu Y, Guo Y, Yao F, Zhang X. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages. J Cell Mol Med. 2020;24(17):9560–9573. doi:10.1111/jcmm.15367.
   PubMed Web of Science ®Google Scholar